LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

2020: First large scale application of AI to protein structure determination: AlfaFold

08/06/2021

Nominated by: UK BioIndustry Association 

Organisation in nomination: DeepMind  

An artificial intelligence (AI) network developed by Google AI offshoot DeepMind made a gargantuan leap in solving one of biology’s grandest challenges — determining a protein’s 3D shape from its amino-acid sequence.

DeepMind’s program, called AlphaFold, outperformed around 100 other teams in a biennial protein-structure prediction challenge called CASP, Critical Assessment of Structure Prediction. The results were announced on 30 November 2020.

AlphaFold can predict the shape of proteins to within the width of an atom. The breakthrough will help scientists design drugs and understand disease.

This is a once in a generation advance, predicting protein structures with incredible speed and precision. This leap forward demonstrates how computational methods are poised to transform research in biology and hold much promise for accelerating the drug discovery process.

The ability to accurately predict protein structures from their amino-acid sequence will be a huge boon to life sciences and medicine. It will vastly accelerate efforts to understand the building blocks of cells and enable quicker and more advanced drug discovery.

The AlphaFold program has already helped solve a protein structure that may lead to a better understanding of how signals are transmitted across cell membranes.

The DeepMind team, based in the UK, also hopes to help identify proteins that misfold, leading to malfunctions that cause disease, and to deliver computer models that may speed up drug discovery and development.

References

  • Improved protein structure prediction using potentials from deep learning, Nature, 15 January 2020
  • DeepMind AI cracks 50-year-old problem of protein folding, The Guardian, 30 November 2020
  • AlphaFold: Using AI for scientific discovery, Blog article
  • ‘It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures, Nature, 30 November 2020
  • DeepMind’s protein-folding AI has solved a 50-year-old grand challenge of biology, MIT Technology Review, 30 November 2020

Back to the list.

Share
Alexandra Simionca
Alexandra Simionca
EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.